The largest database of trusted experimental protocols

Soluble human his rcd40l

Manufactured by R&D Systems
Sourced in United Kingdom

Soluble human his-rCD40L is a recombinant protein that contains the extracellular domain of human CD40 ligand fused to a histidine tag. CD40 ligand is a type II transmembrane protein that belongs to the TNF superfamily and plays a key role in immune cell activation and regulation.

Automatically generated - may contain errors

2 protocols using soluble human his rcd40l

1

Differentiation of Memory B Cells into Antibody-Secreting Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Memory B cells were differentiated in vitro into plasmablasts and plasma cells, following the protocol described in Jourdan et al. (24 (link)). Briefly, CD27+ Memory B cells were first purified as bulk B cells by negative selection from PBMCs by magnetic isolation followed by positive selection for CD27+ cells (Stemcell Technologies, UK) following manufacture's protocol. Then seeded at1.5 × 105 cells/ml, and cultured for 4 days in the presence of CpG oligodeoxynucleotide 2006 (10 μg/ml; Invitrogen), soluble human his-rCD40L (50ng/ml; R&D Systems, UK) and anti-poly-his (5μ g/ml; R&D Systems, UK), IL-2 (20 U/ml; R&D Systems, UK), IL-10 (50 ng/ml; Miltenyi Biotec, UK) and IL-15 (10 ng/ml; Miltenyi Biotec, UK). At day 4 of culture, the cells were washed and cultured at 2.5 × 105 cells/ml with IL-2 (20 U/ml, Milteny Biotec, UK), IL-10 (50 ng/ml), IL-15 (10 ng/m, PreproTech, UK) and IL-6 (50ng/ml; Miltenyi Biotec, UK). At day 7 of culture, cells were washed and seeded with IL-6 (50 ng/ml, PreproTech, UK), IL-15 (10 ng/ml, PreproTech, UK) and IFN-α (500 U/ml; R&D Systems) for 3 days.
+ Open protocol
+ Expand
2

In Vitro Differentiation of Memory B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Memory B cells were differentiated in vitro into plasmablasts and plasma cells, following the protocol described in Jourdan et al. (24 (link)). Briefly, CD27+ Memory B cells were first purified as bulk B cells by negative selection from PBMCs by magnetic isolation followed by positive selection for CD27+ cells (Stemcell Technologies) following the manufacturer’s protocol. The cells were then seeded at 1.5 × 105 cells/ml and cultured for 4 d in the presence of CpG oligodeoxynucleotide 2006 (10 μg/ml; Invitrogen, Paisley, U.K.), soluble human his-rCD40L (50 ng/ml; R&D Systems, Abingdon, U.K.) and anti–poly-his (5 μg/ml; R&D Systems), IL-2 (20 U/ml; R&D Systems), IL-10 (50 ng/ml; Miltenyi Biotec, Surrey, U.K.), and IL-15 (10 ng/ml; Miltenyi Biotec). At day 4 of culture, the cells were washed and cultured at 2.5 × 105 cells/ml with IL-2 (20 U/ml; Miltenyi Biotec), IL-10 (50 ng/ml), IL-15 (10 ng/ml; PeproTech, London, U.K.), and IL-6 (50 ng/ml; Miltenyi Biotec). At day 7 of culture, cells were washed and seeded with IL-6 (50 ng/ml; PeproTech), IL-15 (10 ng/ml; PeproTech), and IFN-α (500 U/ml; R&D Systems) for 3 d.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!